Interestingly, integrated whole-transcriptome and genomic methylation analyses have identified both Frmd4a and Frmd4b as candidate gene products involved in networks specific to late-onset Alzheimer’s disease [39,40]. The gene discussed is FRMD4B; the disease is early-onset autosomal dominant Alzheimer disease.